Temenos Named a Leader in Digital Banking Engagement Platforms and Hub Evaluations by Independent Research Firm
13.9.2021 10:06:00 EEST | Business Wire | Press release
Temenos (SIX: TEMN), the banking software company, today announced that it has been named a leader in two key reports - The Forrester Wave™: Digital Banking Engagement Platforms and Digital Banking Engagement Hubs evaluations for Q3 2021*. Temenos was ranked highest in the strategy category in both evaluations.
Temenos believes this position as a leader in both reports also demonstrates that Temenos Infinity combines a comprehensive digital banking engagement platform with powerful low-code development capabilities that drive business transformation. Temenos attributes the recognition to its leading product strategy, its innovative Explainable AI (XAI) technology and Micro Apps architecture that differentiates Temenos Infinity and drives seamless digital customer experiences.
In both reports, author Jost Hoppermann, Vice President and Principal Analyst, Forrester, wrote: “Temenos convinces with rich banking capabilities and architecture. [It] is a great choice for banks looking for state-of-the-art business capabilities, forward looking architecture and a product strategy that has many ingredients promising more.”
According to the Forrester report the Temenos Quantum multi-experience development platform, “adds low-code capabilities to the mix”, which Temenos believes supports innovation and allows banks to easily adapt to any market or strategic change. This is a key differentiator for Temenos Infinity in transforming the way banks run, build their products, and deliver their services.
Max Chuard, Chief Executive Officer, Temenos, said: “We are proud to be named a Leader in both Forrester Wave reports. This recognition is, in our opinion, a testament to our constant investment and innovation in Temenos Infinity, which is based on the most advanced cloud and AI technology. Temenos Infinity is the platform for business transformation. Over 650 financial institutions worldwide from global tier one banks to digital challengers rely on Temenos Infinity to succeed and grow, and drive exceptional, personal customer experiences. With its open API-first design, Temenos Infinity helps banks connect with a wider ecosystem of financial and non-financial providers to innovate and bring new products to market faster. We believe our position in the Forrester reports is validation of our investment, strategic vision and global customer success.”
The Forester Wave™ evaluates the 11 most significant digital banking engagement platform vendors against 35 (DBEP) and 30 (DBEH), according to their current offering, strategy and market presence. Temenos received the highest possible score in the Apps and Channels and Solution Architecture criteria in the DBEP evaluation and also in the Planned Enhancements, Market Approach and Partner Ecosystem criteria in both evaluations.
In the last 12 months Temenos launched Temenos Infinity Virtual COO, an XAI-powered digital solution which provides data-driven insights and helps banks power SME growth. The company also announced its Temenos Infinity Micro Apps architecture, making it easier for banks to quickly create personalized digital experiences to serve specific segments, like families or students.
*The Forrester Wave™: Digital Banking Engagement Platforms, Q3 2021
The Forrester Wave™: Digital Banking Engagement Hubs, Q3 2021
– Ends –
About Temenos
Temenos AG (SIX: TEMN) is the world’s leader in banking software. Over 3,000 banks across the globe, including 41 of the top 50 banks, rely on Temenos to process both the daily transactions and client interactions of more than 500 million banking customers. Temenos offers cloud-native, cloud-agnostic and AI-driven front office, core banking, payments and fund administration software enabling banks to deliver frictionless, omnichannel customer experiences and gain operational excellence.
Temenos software is proven to enable its top-performing clients to achieve cost-income ratios of 26.8% half the industry average and returns on equity of 29%, three times the industry average. These clients also invest 51% of their IT budget on growth and innovation versus maintenance, which is double the industry average, proving the banks’ IT investment is adding tangible value to their business.
For more information, please visit www.temenos.com.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20210913005268/en/
Contact information
Media Contacts
Jessica Wolfe & Scott Rowe
Temenos Global Public Relations
Tel: +1 610 232 2793 & +44 20 7423 3857
Email : press@temenos.com
Alistair Kellie & Andrew Adie
Newgate Communications on behalf of Temenos
Tel: +44 20 7680 6550
Email: allnewgatetemenos@newgatecomms.com
About Business Wire
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Incyte Announces Positive CHMP Opinion for Zynyz ® (retifanlimab) for First-Line Treatment of Advanced Squamous Cell Carcinoma of the Anal Canal (SCAC)30.1.2026 16:29:00 EET | Press release
Incyte (Nasdaq:INCY) today announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has issued a positive opinion recommending the approval of Zynyz® (retifanlimab) in combination with carboplatin and paclitaxel (platinum-based chemotherapy) for the first-line treatment of adult patients with metastatic or with inoperable locally recurrent squamous cell carcinoma of the anal canal (SCAC). “Today’s positive CHMP opinion is an important step towards addressing the urgent need for new treatment options for patients in Europe with advanced SCAC, a disease which has seen limited innovation for decades,” said Lee Heeson, Executive Vice President and Head of Incyte International. “If approved, Zynyz in combination with platinum-based chemotherapy has the potential to become a new standard-of-care for patients living with this rare and difficult-to-treat cancer.” The positive CHMP opinion was based on data from the Phase 3 POD1UM-303/Inter
Mediawan to Acquire The North Road Company, Creating a New Global Independent Content Platform30.1.2026 14:32:00 EET | Press release
Mediawan, the leading independent European studio led by Pierre-Antoine Capton, co-founded by Capton, Xavier Niel and Matthieu Pigasse, today announced the signing of an agreement to acquire The North Road Company (“North Road”), the preeminent independent U.S.-based studio founded by Peter Chernin. The combination creates one of the world’s largest independent studios with major creative hubs in the five continents and capabilities spanning all genres, formats and audiences. Together, Mediawan and North Road will have a stronger ability to accelerate the development of powerful IP, foster fresh creative synergies through format adaptations and co-production opportunities, and deliver ever greater value to viewers, talent and partners worldwide. The acquisition brings together two of the most dynamic independent studios in the sector with world-class creative talent, premium IP, and the scale to deliver content at the highest level. In an industry undergoing significant consolidation,
BrightSign Powers Intelligent Signage Experiences at ISE 202630.1.2026 10:00:00 EET | Press release
With more industries embracing the power of visual storytelling, BrightSign, the provider of the most advanced, capable, and trusted digital media players and operating system, will showcase the latest developments in digital signage technology at ISE 2026 in Barcelona, Spain from February 3-6, 2026. BrightSign’s latest innovations come to life at booth #4S-150 through interactive real-world demos featuring retail, QSR, transportation, and corporate use cases. Visitors can test new AI-powered object detection capabilities of BrightSign players, allowing them to pick up an object and see the content on the screen respond immediately. Booth activations will be powered by BrightSign’s reliable platform including bsn.Control, BrightSignOS™, brightAuthor connected, and its global partner ecosystem. “In today’s immersive, personalized and visual world, the stakes have never been higher for powerful, secure, reliable, and intelligent digital signage,” said Steve Durkee, chief executive office
Candela Ushers in a New Era of Aesthetic Innovation at IMCAS Paris With the Launch of the Glacē™ System30.1.2026 09:30:00 EET | Press release
Candela, a global leader in energy-based aesthetic technologies, today announced the European launch of the Glacē™ System, a facial treatment platform that signals a bold new chapter for the company and the future of aesthetic medicine. In addition to the launch of the Glacē System, Candela will also showcase its Matrix system for radiofrequency-based skin renewal and its iconic Vbeam® Pro vascular treatment platform at IMCAS 2026. Both Matrix and VBeam Pro platforms are currently available in select EMEA markets and are expected to be comprehensively launched shortly, further strengthening Candela’s leadership in the energy-based device market. Unveiled at the IMCAS World Congress 2026, these launches underscore Candela’s continued commitment to delivering innovative, science-backed treatment solutions for high-demand patient needs. Candela leads the industry in clinical efficacy and safety, supported by one of the largest bodies of published clinical data backed by decades of clinica
Merz Therapeutics Appoints Dan Staner as President, Region Europe30.1.2026 09:00:00 EET | Press release
Merz Therapeutics today announced the appointment of Dan Staner as President, Region Europe, effective February 1, 2026. In this role, Dan will oversee the company’s European business and drive regional growth. Dan will report directly to Merz Therapeutics Chief Executive Officer, Stefan König, and will join the Therapeutics Executive Team. His appointment reflects the company’s continued commitment to strengthening its leadership capabilities and accelerating its growth strategy across key European markets. “Dan brings a strong track record of building and scaling biopharmaceutical businesses across Europe,” said Stefan König, CEO of Merz Therapeutics. “His deep commercial, strategic, and regional leadership experience will be instrumental in advancing our growth ambitions, expanding patient access to our therapies, and further strengthening our presence in Europe. We are very pleased to welcome Dan to Merz Therapeutics.” Throughout his career, Dan has held senior leadership roles i
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
